About LFB

LFB is a biopharmaceutical group that develops, manufactures and markets medicinal products for the treatment of serious and often rare diseases in several major therapeutic fields, namely Hemostasis, Immunology and Intensive Care.
With most of its products indicated for serious and rare diseases, LFB is a major player in this area.
The LFB Group is the leading manufacturer of plasma-derived medicinal products in France and 5th worldwide and is also among the leading European companies for the development of new-generation proteins and treatments based on biotechnologies.
With a sustained investment in research and development, the LFB Group bases its strategy on its international deployment and the design of innovative therapies.

website icon
Website
employees icon
Employees
1,001-5,000 employees View all LFB employees link out icon
industry icon
Industry
Pharmaceuticals
location icon
Location
3 avenue des Tropiques - BP 305 Les Ulis - Zone d'activités de Courtaboeuf, Les Ulis, France 91940, FR
description icon
Founded
1994
description icon
Keywords
Bioproduction, Médicaments Dérivés Du Plasma, Médicaments Issus Du Vivant

Frequently Asked Questions about LFB

Who is the CEO of LFB?

Benjamin Mery is the CEO of LFB. To contact Benjamin Mery email at [email protected] or [email protected]. Or you may call +33.674761746

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more